Universidade Federal de Minas Gerais, Belo Horizonte, MG - Brasil.
Hospital Risoleta Tolentino Neves, Belo Horizonte, MG - Brasil.
Arq Bras Cardiol. 2023 Jun;120(6):e20220576. doi: 10.36660/abc.20220576.
Warfarin is an oral anticoagulant that is very useful in preventing thromboembolism, though it is considered a drug with a high risk of causing adverse events. Considering the practical challenges in controlling oral anticoagulation, the patients on warfarin could benefit from educational strategies aimed at behavioral changes, active participation in self-care, and adherence to drug therapy.
The aim was to construct and validate the EmpoderACO protocol for behavioral changes in warfarin patients.
The methodological steps were: definition of concepts and domains of self-care, identification of objectives, construction and selection of items, assessment of content validity, and pre-test in the target population.
Relevance, adequacy, clarity, and internal reliability of the instrument's items were assessed by a multidisciplinary judges committee (JC) through the E-surv web platform, obtaining an average agreement of ≥0.91. The understanding of the instrument measured by the target population revealed adequate clarity with a coefficient average of 0.96.
EmpoderACO can aid in qualifying the communication process between medical professionals and patients, as well as in improving adherence to both treatment and clinical outcomes, and can be replicated in healthcare settings.
华法林是一种口服抗凝剂，在预防血栓栓塞方面非常有效，但它被认为是一种容易引起不良事件的高风险药物。考虑到控制口服抗凝治疗的实际挑战，接受华法林治疗的患者可以从旨在改变行为、积极参与自我护理和坚持药物治疗的教育策略中受益。
构建并验证针对华法林患者行为改变的 EmpoderACO 方案。
采用的方法步骤包括：自我护理概念和领域的定义、目标的确定、项目的构建和选择、内容有效性评估以及在目标人群中的预测试。
通过 E-surv 网络平台，多学科评判委员会（JC）对仪器项目的相关性、充分性、清晰度和内部可靠性进行了评估，平均达成≥0.91 的共识。目标人群对仪器的理解程度通过平均系数为 0.96 来衡量，表明清晰度良好。
EmpoderACO 可以帮助规范医患之间的沟通流程，提高治疗和临床结果的依从性，并可在医疗保健环境中复制。
